BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McConnell EL, Liu F, Basit AW. Colonic treatments and targets: issues and opportunities. J Drug Target 2009;17:335-63. [PMID: 19555265 DOI: 10.1080/10611860902839502] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Fadda HM, Merchant HA, Arafat BT, Basit AW. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. International Journal of Pharmaceutics 2009;382:56-60. [DOI: 10.1016/j.ijpharm.2009.08.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 5.5] [Reference Citation Analysis]
2 Alhnan MA, Basit AW. Engineering polymer blend microparticles: An investigation into the influence of polymer blend distribution and interaction. European Journal of Pharmaceutical Sciences 2011;42:30-6. [DOI: 10.1016/j.ejps.2010.10.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
3 Pandey M, Choudhury H, Fern JLC, Kee ATK, Kou J, Jing JLJ, Her HC, Yong HS, Ming HC, Bhattamisra SK, Gorain B. 3D printing for oral drug delivery: a new tool to customize drug delivery. Drug Deliv and Transl Res 2020;10:986-1001. [DOI: 10.1007/s13346-020-00737-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
4 Goyanes A, Hatton GB, Basit AW. A dynamic in vitro model to evaluate the intestinal release behaviour of modified-release corticosteroid products. Journal of Drug Delivery Science and Technology 2015;25:36-42. [DOI: 10.1016/j.jddst.2014.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
5 Liu J, Zhang L, Jia Y, Hu W, Zhang J, Jiang H. Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo. Arch Pharm Res 2012;35:1927-34. [DOI: 10.1007/s12272-012-1109-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Marimuthu P, Schätzlein AG. Biological Barriers: Transdermal, Oral, Mucosal, Blood Brain Barrier, and the Blood Eye Barrier. In: Uchegbu IF, Schätzlein AG, Cheng WP, Lalatsa A, editors. Fundamentals of Pharmaceutical Nanoscience. New York: Springer; 2013. pp. 301-36. [DOI: 10.1007/978-1-4614-9164-4_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Shukla RK. Recent advances in oral anticancer agents for colon cancer. Future Oncol 2013;9:1893-908. [PMID: 24295419 DOI: 10.2217/fon.13.137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
8 Krishnaiah YS, Khan MA. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Pharm Dev Technol 2012;17:521-40. [PMID: 22681390 DOI: 10.3109/10837450.2012.696268] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
9 Madani F, Hsein H, Busignies V, Tchoreloff P. An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery. Pharmaceutical Development and Technology 2020;25:133-48. [DOI: 10.1080/10837450.2019.1689402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Jhundoo HD, Siefen T, Liang A, Schmidt C, Lokhnauth J, Moulari B, Béduneau A, Pellequer Y, Larsen CC, Lamprecht A. Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid formulations in experimental colitis. Int J Pharm X 2021;3:100080. [PMID: 33997765 DOI: 10.1016/j.ijpx.2021.100080] [Reference Citation Analysis]
11 Sadeghi F, Eidizade A, Saremnejad F, Hadizadeh F, Khodaverdi E, Akhgari A. Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug. Iran J Basic Med Sci 2020;23:781-7. [PMID: 32695295 DOI: 10.22038/ijbms.2020.41152.9736] [Reference Citation Analysis]
12 Preisig D, Varum F, Bravo R, Hartig C, Spleiss J, Abbes S, Caobelli F, Wild D, Puchkov M, Huwyler J, Haschke M. Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study. Eur J Pharm Biopharm 2021;165:22-30. [PMID: 33971274 DOI: 10.1016/j.ejpb.2021.05.002] [Reference Citation Analysis]
13 Maurer JM, Schellekens RC, van Rieke HM, Stellaard F, Wutzke KD, Buurman DJ, Dijkstra G, Woerdenbag HJ, Frijlink HW, Kosterink JG. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability. J Control Release 2013;172:618-24. [PMID: 24096020 DOI: 10.1016/j.jconrel.2013.09.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
14 Miknevicius P, Zulpaite R, Leber B, Strupas K, Stiegler P, Schemmer P. The Impact of Probiotics on Intestinal Mucositis during Chemotherapy for Colorectal Cancer: A Comprehensive Review of Animal Studies. Int J Mol Sci 2021;22:9347. [PMID: 34502251 DOI: 10.3390/ijms22179347] [Reference Citation Analysis]
15 Dou L, Gavins FKH, Mai Y, Madla CM, Taherali F, Orlu M, Murdan S, Basit AW. Effect of Food and an Animal's Sex on P-Glycoprotein Expression and Luminal Fluids in the Gastrointestinal Tract of Wistar Rats. Pharmaceutics 2020;12:E296. [PMID: 32218182 DOI: 10.3390/pharmaceutics12040296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Sauer J, Merchant H. Physiology of the Gastrointestinal System. Comprehensive Toxicology. Elsevier; 2018. pp. 16-44. [DOI: 10.1016/b978-0-12-801238-3.99195-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Varum F, Hatton G, Freire A, Basit A. A novel coating concept for ileo-colonic drug targeting: Proof of concept in humans using scintigraphy. European Journal of Pharmaceutics and Biopharmaceutics 2013;84:573-7. [DOI: 10.1016/j.ejpb.2013.01.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
18 Goyanes A, Hatton GB, Merchant HA, Basit AW. Gastrointestinal release behaviour of modified-release drug products: Dynamic dissolution testing of mesalazine formulations. International Journal of Pharmaceutics 2015;484:103-8. [DOI: 10.1016/j.ijpharm.2015.02.051] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
19 Kim MS, Yeom DW, Kim SR, Yoon HY, Kim CH, Son HY, Kim JH, Lee S, Choi YW. Development of a chitosan based double layer-coated tablet as a platform for colon-specific drug delivery. Drug Des Devel Ther 2017;11:45-57. [PMID: 28053506 DOI: 10.2147/DDDT.S123412] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
20 Gunasekara DB, Speer J, Wang Y, Nguyen DL, Reed MI, Smiddy NM, Parker JS, Fallon JK, Smith PC, Sims CE, Magness ST, Allbritton NL. A Monolayer of Primary Colonic Epithelium Generated on a Scaffold with a Gradient of Stiffness for Drug Transport Studies. Anal Chem 2018;90:13331-40. [PMID: 30350627 DOI: 10.1021/acs.analchem.8b02845] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
21 Freire AC, Basit AW, Choudhary R, Piong CW, Merchant HA. Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery. International Journal of Pharmaceutics 2011;415:15-28. [DOI: 10.1016/j.ijpharm.2011.04.069] [Cited by in Crossref: 110] [Cited by in F6Publishing: 93] [Article Influence: 10.0] [Reference Citation Analysis]
22 Vieira AC, Murdan S, Serra AC, Veiga FJ, Gonsalves AMDR, Basit AW. Influence of feeding regimens on rat gut fluids and colonic metabolism of diclofenac-β-cyclodextrin. Carbohydrate Polymers 2014;112:758-64. [DOI: 10.1016/j.carbpol.2014.06.064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Varum F, Freire AC, Fadda HM, Bravo R, Basit AW. A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug release. Int J Pharm 2020;583:119379. [PMID: 32360546 DOI: 10.1016/j.ijpharm.2020.119379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
24 Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm 2015;89:157-62. [PMID: 25497178 DOI: 10.1016/j.ejpb.2014.12.003] [Cited by in Crossref: 308] [Cited by in F6Publishing: 274] [Article Influence: 38.5] [Reference Citation Analysis]
25 Varum F, Hatton G, Basit A. Food, physiology and drug delivery. International Journal of Pharmaceutics 2013;457:446-60. [DOI: 10.1016/j.ijpharm.2013.04.034] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 8.2] [Reference Citation Analysis]
26 Bermejo M, Sanchez-dengra B, Gonzalez-alvarez M, Gonzalez-alvarez I. Oral controlled release dosage forms: dissolution versus diffusion. Expert Opinion on Drug Delivery 2020;17:791-803. [DOI: 10.1080/17425247.2020.1750593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kim JM, Kim DH, Park HJ, Ma HW, Park IS, Son M, Ro SY, Hong S, Han HK, Lim SJ, Kim SW, Cheon JH. Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model. J Nanobiotechnology 2020;18:133. [PMID: 32933548 DOI: 10.1186/s12951-020-00693-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Foppoli A, Maroni A, Moutaharrik S, Melocchi A, Zema L, Palugan L, Cerea M, Gazzaniga A. In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release. International Journal of Pharmaceutics 2019;572:118723. [DOI: 10.1016/j.ijpharm.2019.118723] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
29 Hatton GB, Yadav V, Basit AW, Merchant HA. Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans. Journal of Pharmaceutical Sciences 2015;104:2747-76. [DOI: 10.1002/jps.24365] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 13.7] [Reference Citation Analysis]
30 Abaci A, Gedeon C, Kuna A, Guvendiren M. Additive Manufacturing of Oral Tablets: Technologies, Materials and Printed Tablets. Pharmaceutics 2021;13:156. [PMID: 33504009 DOI: 10.3390/pharmaceutics13020156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
31 Ranjbar S, Seyednejad SA, Azimi H, Rezaeizadeh H, Rahimi R. Emerging Roles of Probiotics in Prevention and Treatment of Breast Cancer: A Comprehensive Review of Their Therapeutic Potential. Nutr Cancer 2019;71:1-12. [PMID: 30686054 DOI: 10.1080/01635581.2018.1557221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
32 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2021;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Reference Citation Analysis]
33 Wang J, Yadav V, Smart AL, Tajiri S, Basit AW. Stability of peptide drugs in the colon. Eur J Pharm Sci 2015;78:31-6. [PMID: 26111980 DOI: 10.1016/j.ejps.2015.06.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
34 Pentafragka C, Symillides M, Mcallister M, Dressman J, Vertzoni M, Reppas C. The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL review. Journal of Pharmacy and Pharmacology 2019;71:557-80. [DOI: 10.1111/jphp.12999] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
35 Merchant HA, Mcconnell EL, Liu F, Ramaswamy C, Kulkarni RP, Basit AW, Murdan S. Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. European Journal of Pharmaceutical Sciences 2011;42:3-10. [DOI: 10.1016/j.ejps.2010.09.019] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
36 Kim W, Kim S, Ju S, Lee H, Jeong S, Yoo J, Yoon I, Jung Y. Colon-Targeted Delivery Facilitates the Therapeutic Switching of Sofalcone, a Gastroprotective Agent, to an Anticolitic Drug via Nrf2 Activation. Mol Pharmaceutics 2019;16:4007-16. [DOI: 10.1021/acs.molpharmaceut.9b00664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. Oligonucleotides-A Novel Promising Therapeutic Option for IBD. Front Pharmacol 2019;10:314. [PMID: 31068803 DOI: 10.3389/fphar.2019.00314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
38 Shukla RK, Tiwari A. Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon. Carbohydrate Polymers 2012;88:399-416. [DOI: 10.1016/j.carbpol.2011.12.021] [Cited by in Crossref: 133] [Cited by in F6Publishing: 87] [Article Influence: 13.3] [Reference Citation Analysis]
39 Schellekens RC, Baltink JH, Woesthuis EM, Stellaard F, Kosterink JG, Woerdenbag HJ, Frijlink HW. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics. Pharm Dev Technol 2012;17:40-7. [PMID: 20923321 DOI: 10.3109/10837450.2010.513986] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
40 McCoubrey LE, Elbadawi M, Orlu M, Gaisford S, Basit AW. Harnessing machine learning for development of microbiome therapeutics. Gut Microbes 2021;13:1-20. [PMID: 33522391 DOI: 10.1080/19490976.2021.1872323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
41 Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, Gaisford S, Basit AW. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm 2015;496:414-20. [PMID: 26481468 DOI: 10.1016/j.ijpharm.2015.10.039] [Cited by in Crossref: 180] [Cited by in F6Publishing: 156] [Article Influence: 25.7] [Reference Citation Analysis]
42 Basit AW, Mcconnell EL. Drug Delivery to the Colon. In: Wilson CG, Crowley PJ, editors. Controlled Release in Oral Drug Delivery. Boston: Springer US; 2011. pp. 385-99. [DOI: 10.1007/978-1-4614-1004-1_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 2019;558:201-14. [DOI: 10.1016/j.ijpharm.2018.12.074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
44 Rai G, Yadav AK, Jain NK, Agrawal GP. Enteric-coated epichlorohydrin crosslinked dextran microspheres for site-specific delivery to colon. Drug Development and Industrial Pharmacy 2015;41:2018-28. [DOI: 10.3109/03639045.2015.1044901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
45 Christfort JF, Guillot AJ, Melero A, Thamdrup LHE, Garrigues TM, Boisen A, Zór K, Nielsen LH. Cubic Microcontainers Improve In Situ Colonic Mucoadhesion and Absorption of Amoxicillin in Rats. Pharmaceutics 2020;12:E355. [PMID: 32295139 DOI: 10.3390/pharmaceutics12040355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
46 Maurer JM, Hofman S, Schellekens RC, Tonnis WF, Dubois AO, Woerdenbag HJ, Hinrichs WL, Kosterink JG, Frijlink HW. Development and potential application of an oral ColoPulse infliximab tablet with colon specific release: A feasibility study. International Journal of Pharmaceutics 2016;505:175-86. [DOI: 10.1016/j.ijpharm.2016.03.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
47 Smart AL, Gaisford S, Basit AW. Oral peptide and protein delivery: intestinal obstacles and commercial prospects. Expert Opinion on Drug Delivery 2014;11:1323-35. [DOI: 10.1517/17425247.2014.917077] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 9.3] [Reference Citation Analysis]
48 Garbacz G, Rappen GM, Koziolek M, Weitschies W. Dissolution of mesalazine modified release tablets under standard and bio-relevant test conditions. J Pharm Pharmacol 2015;67:199-208. [PMID: 25557626 DOI: 10.1111/jphp.12332] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
49 Varum F, Freire AC, Bravo R, Basit AW. OPTICORE™, an innovative and accurate colonic targeting technology. Int J Pharm 2020;583:119372. [PMID: 32344022 DOI: 10.1016/j.ijpharm.2020.119372] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
50 Vieira AC, Serra AC, Carvalho RA, Gonsalves A, Figueiras A, Veiga FJ, Basit AW, Rocha Gonsalves AM. Microwave synthesis and in vitro stability of diclofenac-β-cyclodextrin conjugate for colon delivery. Carbohydr Polym 2013;93:512-7. [PMID: 23499091 DOI: 10.1016/j.carbpol.2012.12.053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
51 Dehghan MH, Gupta VR, Asif SM, Darwis Y, Rizwan M, Mundada VP. Assessment of isomalt for colon-specific delivery and its comparison with lactulose. AAPS PharmSciTech 2013;14:53-9. [PMID: 23225025 DOI: 10.1208/s12249-012-9886-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
52 McCartney F, Rosa M, Brayden DJ. Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies. Pharmaceutics 2019;11:E565. [PMID: 31683652 DOI: 10.3390/pharmaceutics11110565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
53 Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. Journal of Controlled Release 2011;153:106-16. [DOI: 10.1016/j.jconrel.2011.01.027] [Cited by in Crossref: 290] [Cited by in F6Publishing: 242] [Article Influence: 26.4] [Reference Citation Analysis]
54 Maurer JM, Schellekens RC, van Rieke HM, Wanke C, Iordanov V, Stellaard F, Wutzke KD, Dijkstra G, van der Zee M, Woerdenbag HJ, Frijlink HW, Kosterink JG. Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets. PLoS One. 2015;10:e0129076. [PMID: 26177019 DOI: 10.1371/journal.pone.0129076] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
55 Sahu KK, Pandey RS. Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles. Int Immunopharmacol 2016;39:343-52. [PMID: 27526270 DOI: 10.1016/j.intimp.2016.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
56 Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
57 Yadav V, Mai Y, McCoubrey LE, Wada Y, Tomioka M, Kawata S, Charde S, Basit AW. 5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines 2021;9:578. [PMID: 34065300 DOI: 10.3390/biomedicines9050578] [Reference Citation Analysis]
58 Maroni A, Zema L, Del Curto MD, Foppoli A, Gazzaniga A. Oral colon delivery of insulin with the aid of functional adjuvants. Advanced Drug Delivery Reviews 2012;64:540-56. [DOI: 10.1016/j.addr.2011.10.006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]